Adiponectin measures indicate pain severity, study suggests

03/21/2013 | MedPage Today (free registration)

A small study that included 20 women with migraines found that adiponectin measures could predict pain severity and treatment response, Johns Hopkins University researchers reported in the journal Headache. Ratios of high-to-low molecular weight adiponectin could be tied to severity of pain, indicating the potential for use as a migraine biomarker and drug target.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC